Login / Signup

Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.

Jennifer LoskeJ RöhmelSoeren LukassenS StrickerV G MagalhãesJohannes LiebigRobert Lorenz ChuaLoreen ThürmannMarey MessingschlagerA SeegebarthB TimmermannS KlagesM RalserBirgit SawitzkiLeif-Erik SanderVictor Max CormanC ConradSven LaudiMarco BinderSaskia TrumpRoland EilsMarcus Alexander MallIrina Lehmann
Published in: Nature biotechnology (2021)
Children have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates and a substantially lower risk for developing severe coronavirus disease 2019 compared with adults. However, the molecular mechanisms underlying protection in younger age groups remain unknown. Here we characterize the single-cell transcriptional landscape in the upper airways of SARS-CoV-2-negative (n = 18) and age-matched SARS-CoV-2-positive (n = 24) children and corresponding samples from adults (n = 44), covering an age range of 4 weeks to 77 years. Children displayed higher basal expression of relevant pattern recognition receptors such as MDA5 (IFIH1) and RIG-I (DDX58) in upper airway epithelial cells, macrophages and dendritic cells, resulting in stronger innate antiviral responses upon SARS-CoV-2 infection than in adults. We further detected distinct immune cell subpopulations including KLRC1 (NKG2A)+ cytotoxic T cells and a CD8+ T cell population with a memory phenotype occurring predominantly in children. Our study provides evidence that the airway immune cells of children are primed for virus sensing, resulting in a stronger early innate antiviral response to SARS-CoV-2 infection than in adults.
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • young adults
  • immune response
  • dendritic cells
  • cystic fibrosis
  • gene expression
  • cell death
  • signaling pathway
  • single molecule
  • rna seq
  • binding protein